共 160 条
- [1] Siegel R.L., Miller K.D., Fuchs H.E., Jemal A., Cancer statistics, 2021, CA Cancer J. Clin, 71, pp. 7-33, (2021)
- [2] Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries, Lancet, 397, pp. 387-397, (2021)
- [3] Wang J., Zhu M., Nie G., Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles, Adv Drug Deliv Rev, 178, (2021)
- [4] Chung S., Revia R.A., Zhang M., Graphene quantum dots and their applications in bioimaging, biosensing, and therapy, Adv Mater, 33, (2021)
- [5] Zivojevic K., Mladenovic M., Djisalov M., Mundzic M., Ruiz-Hernandez E., Gadjanski I., Et al., Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications, J Control Release, 337, pp. 193-211, (2021)
- [6] Wang S., Liu X., Yang M., Ouyang L., Ding J., Wang S., Et al., Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy, Asian J Pharm, 17, pp. 557-570, (2022)
- [7] Wang C., Wang J., Pan X., Yu S., Chen M., Gao Y., Et al., Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis, Asian J Pharm, 18, (2023)
- [8] Medici S., Peana M., Coradduzza D., Zoroddu M.A., Gold nanoparticles and cancer: detection, diagnosis and therapy, Semin Cancer Biol, 76, pp. 27-37, (2021)
- [9] Wuttke S., Lismont M., Escudero A., Rungtaweevoranit B., Parak W.J., Positioning metal-organic framework nanoparticles within the context of drug delivery – a comparison with mesoporous silica nanoparticles and dendrimers, Biomaterials, 123, pp. 172-183, (2017)
- [10] Mallakpour S., Nikkhoo E., Hussain C.M., Application of MOF materials as drug delivery systems for cancer therapy and dermal treatment, Coord Chem Rev, 451, (2022)